Cyonanz
Cyonanz (Norethindrone and Ethinyl Estradiol Tablets, USP) 0.5 mg/0.035 mg Rx only
Approved
Approval ID
2bd1b72e-fba5-4275-a02a-ed08a5434a92
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 3, 2021
Manufacturers
FDA
Aurobindo Pharma Limited
DUNS: 650082092
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Norethindrone and Ethinyl Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code65862-899
Application NumberANDA207055
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone and Ethinyl Estradiol
Product Specifications
Effective DateDecember 3, 2021
FDA Product Classification